Denver, Colorado: The Radiosurgery Society is meeting this week in Minneapolis, MN to advance the standard of care for stereotactic radiosurgery (SRS) and stereotactic body radiation therapy (SBRT). Experts in the field of radiosurgery will present research findings, discuss best practices and collaborate toward elevating the standard of care. Mirada Medical is presenting how its DIR algorithms and RTx software tools can improve the accuracy required in radiosurgery treatment planning.

"Mirada addresses clinical problems such as accurate target definition, automated delineation of critical structures and dose deformation for multiple modality treatment strategies," states Cristian Cotrutz, PhD of Swedish Cancer Institute in Seattle.

Mirada has been recognized worldwide for its leadership in DIR algorithm accuracy for more than a decade. As radiosurgery technology has increased in sophistication in recent years, Mirada has responded with a suite of software tools designed to support accurate target definition for SRS/SBRT.

Paul Meskell, VP at Mirada Medical adds, "We are delighted that our tools have aided the radiosurgery treatment planning process at elite institutions such as Swedish Cancer Institute, and look forward to introducing Mirada's technology to the radiosurgery community at this important meeting".

The latest innovations in Mirada's RTx radiotherapy software suite will be presented in Booth #2 during the annual SRS/SBRT meeting.

For more information, please contact:

Mirada Medical
US/Worldwide: Robert Ripley
Tel: (440) 591-8638

Insource Communications
rripley@insourceinc.com
enquiries@mirada-medical.com

www.mirada-medical.com

U.S. Headquarters:

Mirada Medical USA, Inc.
999 18th Street
Suite 2025N
Denver, CO 80202
Tel: (303) 379-9228

World Headquarters:

Oxford Centre for Innovation
New Road, Oxford
OX1 1BY
United Kingdom
Tel: +44 (0) 1865 261410

About Mirada Medical Ltd

Mirada Medical is a prominent global brand in medical imaging software. Mirada's innovative software solutions are routinely used in radiology, molecular imaging, radiation oncology and in multidisciplinary meetings throughout hospitals, imaging centers and cancer centers worldwide. Mirada excels at combining scientifically advanced technology with practical application for diagnosis, management and treatment of cancer and other diseases. Mirada products are available directly from the company, and also through a broad network of well-known healthcare companies such as Varian, GE, McKesson, Siemens, Vital Images and select others. Mirada was originally founded in 2001 by medical imaging researchers at Oxford University. The company's world headquarters remains in Oxford, England and continues to attract preeminent talent in science and engineering.

Mirada Medical, RTx, Casemeeting, Caseaccess and XD3 are all trademarks of Mirada Medical Ltd.